Stock Details
MDT is Medtronic plc's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 98.60$. Average daily volumn in 3 months 5.9M. Market cap 121.42B



Stock symbol : MDT. Exchange : NYSE. Currency : USD
Lastest price : 91.38$. Total volume : 3.99M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Medtronic plc (MDT)
Last Price
91.38$
Change
1.63
Volume
3.99M

Previous Close89.75
Open89.76
Day Range89.06-91.54
Bid89.80 x 800
Ask91.69 x 800
Volume3.99M
Average Volume5.9M
Market Cap121.42B
Beta0.75
52 Week Range86.95-135.89
Trailing P/E24.50
Foward P/E15.15
Dividend (Yield %)2.98%
Ex-Dividend Date2022-06-23



Financial Details


According to Medtronic plc's financial reports the company's revenue in 2022 were 31.69B an increase( +3.33%) over the years 2021 revenue that were of 30.12B. In 2022 the company's total earnings were 5.04B while total earnings in 2021 were 3.61B( +66.67%).


Loading ...



Organization

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repa... ir products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Market Cap:
121.42B
Revenue:
31.69B
Total Assets:
90.98B
Total Cash:
3.71B


News about "Medtronic plc"

medtronic-plc-nysemdt-holdings-lowered-by-ae-wealth-management-llc-image

Medtronic plc (NYSE:MDT) Holdings Lowered by AE Wealth Management LLC

Source from : Defense World - 3 days ago

AE Wealth Management LLC lowered its stake in Medtronic plc (NYSE:MDT โ€“ Get Rating) by 7.5% during the first quarter, HoldingsChannel reports. The firm owned 45,963 shares of the medical technology ...See details»


ellevest-inc-boosts-stock-position-in-medtronic-plc-nysemdt-image

Ellevest Inc. Boosts Stock Position in Medtronic plc (NYSE:MDT)

Source from : Defense World - 2 days ago

Ellevest Inc. grew its stake in shares of Medtronic plc (NYSE:MDT โ€“ Get Rating) by 38.5% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange ...See details»


Medtronic plc (MDT) Is A Good Investment At Current Valuations

Source from : stocksregister - 4 days ago

Medtronic plc (NYSE:MDT) at last check was buoying at $89.83 on Thursday, June 30, with a fall of -0.65% from its closing price on previous day. Taking a look at stock we notice that its last check on ...See details»


are-poor-financial-prospects-dragging-down-medtronic-plc-nysemdt-stock-image

Are Poor Financial Prospects Dragging Down Medtronic plc (NYSE:MDT Stock?

Source from : Yahoo News UK - 7 days ago

Medtronic (NYSE:MDT) has had a rough three months with its share price down 18%. We decided to study the company's financials to determine if the downtrend will continue as the long-term performance ...See details»


private-trust-co-na-has-132-million-position-in-medtronic-plc-nysemdt-image

Private Trust Co. NA Has $1.32 Million Position in Medtronic plc (NYSE:MDT)

Source from : ETF Daily News - 11 days ago

Private Trust Co. NA cut its holdings in shares of Medtronic plc (NYSE:MDT โ€“ Get Rating) by 32.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange ...See details»


supply-chain-evp-greg-smith-sees-fewer-suppliers-in-medtronics-future-image

Supply Chain EVP Greg Smith sees fewer suppliers in Medtronicโ€™s future

Source from : Medical Design and Outsourcing - 3 days ago

In his first interview since joining Medtronic, Smith identified what he thinks is one of the biggest opportunities for the medtech giant.See details»


acutus-completes-first-closing-in-left-heart-access-portfolio-sale-to-medtronic-image

Acutus completes first closing in left-heart access portfolio sale to Medtronic

Source from : MassDevice - 3 days ago

Acutus Medical (Nasdaq:AFIB) announced today that it completed the first of two closings in its portfolio sale to Medtronic (NYSE:MDT). Carlsbad, California-based Acutus announced in April that it ...See details»


ex-dividend-reminder-dentsply-sirona-medtronic-and-danaher-image

Ex-Dividend Reminder: DENTSPLY SIRONA, Medtronic and Danaher

Source from : Nasdaq - 13 days ago

Looking at the universe of stocks we cover at Dividend Channel, on 6/23/22, DENTSPLY SIRONA Inc (Symbol: XRAY), Medtronic PLC (Symbol: MDT), and Danaher Corp (Symbol: DHR) will all trade ex-dividend ...See details»


Acutus Medical Completes First Closing of Transaction with Medtronic and Debt Refinancing to Fund Strategic Growth Priorities

Source from : Associated Press - 3 days ago

We continue to advance our strategic initiatives to drive adoption of our differentiated mapping and therapy platform as well as improve our financial and operational performance,โ€ said David Roman, ...See details»


medtronic-board-appoints-lidia-fonseca-as-a-new-director-image

Medtronic Board appoints Lidia Fonseca as a new director

Source from : WFMZ-TV - 7 days ago

Medtronic plc (NYSE: MDT) today announced that its Board of Directors appointed Lidia Fonseca, Executive Vice President, Chief Digital and Technology Officer at Pfizer, ...See details»


how-unitedhealth-medtronic-wells-fargo-and-others-are-responding-to-roe-rulings-impact-on-employees-image

How UnitedHealth, Medtronic, Wells Fargo and others are responding to Roe ruling's impact on employees

Source from : The Business Journals - 6 days ago

Many Minnesota employers have big decisions to make on how they'll handle health coverage for abortions, and whether they'll help workers travel to states that allow them.See details»


medtronics-spine-implant-seaspines-interbody-launch-and-more-4-device-company-notes-image

Medtronic's spine implant, SeaSpine's interbody launch and more: 4 device company notes

Source from : Becker's Spine Review - 5 days ago

SeaSpine's latest commercial launch and three other updates from spine devicemakers Becker's has covered since June 22: ...See details»


medtronic-board-taps-pfizer-executive-as-independent-director-image

Medtronic board taps Pfizer executive as independent director

Source from : Becker's Spine Review - 7 days ago

Medtronic named Lidia Fonseca as an independent director of its board of directors. Ms. Fonseca, executive vice president and chief digital and technology officer at Pfizer, will serve on Medtronic's ...See details»


another-medtronic-hvad-recall-is-serious-image

Another Medtronic HVAD recall is serious

Source from : MassDevice - 11 days ago

A year after Medtronic ceded the LVAD market to Abbott, it has yet another Class I recall involving its HVAD pumps still inside patients.See details»